COVID-19 and the Physio4FMD trial: Impact, mitigating strategies and analysis plans
Authors:
- Louise MarstonLMLouise Marston
- Marie Le NovereMNMarie Le Novere
- Irwin NazarethINIrwin Nazareth
- Alan CarsonACAlan Carson
- Mark EdwardsMEMark Edwards
- Laura H. GoldsteinLGLaura H. Goldstein
- Jonathan MarsdenJMJonathan Marsden
- Hayley NobleHNHayley Noble
- Markus ReuberMRMarkus Reuber
- Jon StoneJSJon Stone
- Rachael M. HunterRachael M. Hunter
Open Access
- 24 March 2023
- journal article
- research article
- Published by Elsevier in Contemporary Clinical Trials Communications
- Vol. 33, 101124
Abstract
No abstract availableKeywords
Funding Information
- King's College London
- National Institute for Health and Care Research
- Health Technology Assessment Programme (16/31/63)
This publication has 33 references indexed in Scilit:
- Interim Scoring for the EQ-5D-5L: Mapping the EQ-5D-5L to EQ-5D-3L Value SetsValue in Health, 2012
- Guided self-help for functional (psychogenic) symptomsNeurology, 2011
- Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L)Quality of Life Research, 2011
- Productivity and HealthJournal of Occupational and Environmental Medicine, 2011
- Intention-to-treat concept: A reviewPerspectives in Clinical Research, 2011
- The Functional Mobility Scale (FMS)Journal of Pediatric Orthopaedics, 2004
- The Revised Illness Perception Questionnaire (IPQ-R)Psychology & Health, 2002
- Statistical techniques for analyzing data from prevention trials: Treatment of no-shows using Rubin's causal model.Psychological Methods, 1998
- The Hospital Anxiety and Depression ScaleActa Psychiatrica Scandinavica, 1983
- Specification Tests in EconometricsEconometrica, 1978